E. De Clercq

Infectious Diseases · 2003–2020

A researcher in the Science corpus: 4 papers; trusts 3 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom E. De Clercq trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. P. Palese
  2. A. Moscona
  3. Neil M. Ferguson
  4. Yoshihiro Kawaoka

Who trusts E. De Clercq overall

  1. Martin Egli
  2. Shasha Liu
  3. Guangdi Li

Papers from E. De Clercq's perspective

Ordered by how strongly the researchers E. De Clercq trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. (Journal of the American Medical Association (JAMA))
  2. Influenza Pandemics of the 20th Century (Emerging Infectious Diseases)
  3. Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection (Antimicrobial Agents and Chemotherapy)
  4. Neuraminidase Is Important for the Initiation of Influenza Virus Infection in Human Airway Epithelium (Journal of Virology)
  5. Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset (Journal of Infectious Diseases)
  6. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses (Science Translational Medicine)
  7. Strategies for mitigating an influenza pandemic (Nature)
  8. Influenza: old and new threats (Nature Medicine)
  9. Avian flu: Influenza virus receptors in the human airway (Nature)
  10. Influenza: lessons from past pandemics, warnings from current incidents (Nature Reviews Microbiology)

Their papers